Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (4): 487-492.doi: 10.12092/j.issn.1009-2501.2025.04.006

Previous Articles     Next Articles

The role of ADAM10/Notch3 signaling pathway in the proliferation of rat PASMCs and intervention of total saponins of Panax notoginseng 

HUANG Man1, BAI Xiangshu2, TIAN Yunna1, XU Junpeng1, WANG Xiaoting1, ZHANG Sai1, YUAN Linbo3, WANG Wantie1   

  1. 1Department of Pathology and Pathophysiology, School of Basic Medicine, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China; 2Public Health Department of Pingyang County People's Hospital, Pingyang 325400, Zhejiang, China; 3Department of Functions, School of Basic Medicine, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
  • Received:2024-04-01 Revised:2024-05-30 Online:2025-04-26 Published:2025-04-09

Abstract:

AIM: To investigate the effect and mechanism of panax notoginseng saponins (PNS) inhibiting the proliferation of pulmonary artery smooth muscle cells (PASMCs) in rats under the effect of monocrotaline (MCT). METHODS: PASMCs cultured in vitro were randomly divided into the normal control (Control) group, the monocrotaline (MCT) group, the panax notoginseng saponins (PNS) group, the knockdown (M+Si ADAM10) group, the knockdown postconditioning (M+P+Si ADAM10) group, the overexpression (M+OE ADAM10) group, and the overexpression postconditioning (M+P+OE ADAM10) group. After the model was constructed, the cell viability of each group was measured using the CCK-8 assay, along with Western blot utilized to detect the expression of proliferating cell nuclear antigen (PCNA), disintegrin metalloproteinase 10 (ADAM10), and notch homology protein-3 (Notch3) at the cellular neurogenic locus, respectively. RESULTS:Under the effect of MCT, the viability of PASMCs was significantly enhanced (P<0.05 or P<0.01); 0-400 mg/L PNS was not toxic to the viability of normal cells, and 100 mg/L PNS could significantly inhibit the MCT-induced viability (P<0.01). After the knockdown of ADAM10, the viability of PASMCs significantly declined (P<0.01),and the expression of PCNA protein was significantly decreased (P<0.05), evidently in the M+P+Si ADAM10 group. Meanwhile, the expression of ADAM10 and Notch3 protein was significantly decreased (P<0.05 or P<0.01), evidently in the M+P+Si ADAM10 group. After overexpression of ADAM10, the viability of PASMCs was significantly enhanced (P<0.01), the expression of PCNA protein was significantly increased (P<0.01), the PCNA value was slightly higher (P>0.05), and the expression of ADAM10 and Notch3 protein was significantly elevated (P<0.05) in the M+P+OE ADAM10 group. Additionally, PASMCs overexpressing ADAM10 with concomitant PNS exhibited a significant decrease in the expression of PCNA protein compared with PASMCs knocking down ADAM10 (P<0.01), and the expression of ADAM10 and Notch3 protein declined to varying degrees (P>0.05).CONCLUSION: Panax notoginseng saponins can mitigate MCT-induced PASMCs proliferation in rats by inhibiting the ADAM10/Notch3 signaling pathway.

Key words: pulmonary artery smooth muscle cells, panax notoginseng saponins, monocrotaline, ADAM10/Notch3 pathway, rats

CLC Number: